Citius Oncology Inc.

1.21
0.01 (0.83%)
At close: Jan 30, 2025, 11:35 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21
Revenue n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a
Operating Income -20.57M -12.12M -4.86M n/a
Interest Income n/a n/a n/a n/a
Pretax Income -20.57M -12.12M -4.86M -10.11K
Net Income -21.15M -12.70M -5.43M -10.11K
Selling & General & Admin 15.65M 7.88M 1.43M n/a
Research & Development 4.93M 4.24M 3.43M n/a
Other Expenses n/a n/a n/a n/a
Operating Expenses 20.57M 12.12M 4.86M n/a
Interest Expense n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 20.57M 12.12M 4.86M n/a
Income Tax 576.00K 576.00K 576.00K n/a
Shares Outstanding (Basic) n/a n/a 9.02M 8.14M
Shares Outstanding (Diluted) n/a n/a 9.02M 8.14M
EPS (Basic) n/a n/a 0.04 -0.00
EPS (Diluted) n/a n/a 0.04 -0.00
EBITDA -20.57M -12.12M -4.86M -10.11K
Depreciation & Amortization n/a n/a n/a n/a